Providing market intelligence for more than 35 years

In The News

No, Apple's licensing of iTunes & AirPlay 2 isn't a 'strategy reversal' in any way

That claim cited research by Parks Associates, which actually showed that Apple TV's share by installed base was not drying up and blowing away as Mims portrayed, but was actually better than Google's and far ahead of Sony or Tivo.

It also stated that consumers rated Apple TV highly in setup, usability, gaming, and for purchasing content. It also noted that almost half of smart TV owners also used a streaming media player and that they used their media player much more frequently than their TV's built-in services. Yet Mims was so desperate to take swipes at Apple that he fudged the findings of that research. None of those facts fit his narrative of the "failing Apple TV that nobody uses," so he left them out.  

From the article "No, Apple's licensing of iTunes & AirPlay 2 isn't a 'strategy reversal' in any way" by Daniel Erin Dilger.

Previously In The News

15 Percent of U.S. Broadband Households Plan to Buy Wireless Speakers

A recent Parks Research study found that, of U.S. broadband households, 18 percent plan to buy earbuds over the next 12 months, 16 percent plan to buy headphones, and 15 percent plan to buy wireless s...

Cord Cutters Face A Sea Of Streaming Options

Hartstein’s decision was made easier because of a flood of Internet streaming services that allows consumers to cobble together their own video packages. There are more than 100 Internet video service...

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...